| Next 10 |
Ad
TSVT News and Press 2seventy bio Inc.
News | 2seventy bio Inc. (NASDAQ:TSVT)
-
2024-09-25 06:49:50 ET More on Bristol-Myers Squibb, 2seventy bio, etc. Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely Prolonged Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade) Bristol-Myers Squib...
-
2seventy and Bristol Myers Squibb discontinue enrollment in Phase 3 KarMMa-9 study Decision results in over $80 million in anticipated cost savings for 2seventy over the next several years and accelerates path to breakeven in 2025 Expanded 3L+ label drives re-acceleration in Abe...
-
2seventy bio, Inc . (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22 nd Annual Global Healthcare Conference on September 6, 2024 at 12:20 p.m. ET in New York. A live webcast of the fireside chat wil...
-
2024-08-11 04:52:09 ET 2seventy bio, Inc. (TSVT) Q2 2024 Earnings Conference Call August 07, 2024, 08:00 AM ET Company Participants Jenn Snyder - Senior Vice President, Corporate Affairs William Baird - Chief Executive Officer Vicki Eatwell - Chief Financial Offi...
-
2024-08-07 09:46:18 ET More on 2seventy bio 2seventy bio's Abecma: Compelling Investment In Multiple Myeloma Despite Competition Novo Nordisk buys 2seventy bio’s Hemophilia A program Read the full article on Seeking Alpha For further details see: 2...
-
2seventy bio, Inc . (Nasdaq: TSVT) will announce its second quarter 2024 financial results on Wednesday, August 7, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available on the Investors and Medi...
-
2024-07-09 07:06:25 ET Summary 2seventy bio, Inc. focuses on Abecma, an FDA-approved CAR T cell therapy for multiple myeloma. TSVT's strategic realignment includes selling non-core assets to Regeneron and Novo Nordisk. Abecma shows favorable clinical data but faces strong comp...
-
2024-07-02 08:23:40 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strateg...
-
2024-06-27 06:56:19 ET More on Novo Nordisk Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Novo Nordisk: Leading The Fight Against Diabetes And Obesity Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk hypertensio...
-
- Divestiture Supports Company Focus on Development and Commercialization of Abecma - 2seventy bio, Inc . (Nasdaq: TSVT), announced today the completion of an asset purchase agreement (“APA”) by Novo Nordisk. Under the terms of the APA, Novo Nordisk has acquired th...
Stock Information
Get TSVT Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2seventy and Bristol Myers Squibb discontinue enrollment in Phase 3 KarMMa-9 study Decision results in over $80 million in anticipated cost savings for 2seventy over the next several years and accelerates path to breakeven in 2025 Expanded 3L+ label drives re-acceleration in Abe...
-
2seventy bio, Inc . (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22 nd Annual Global Healthcare Conference on September 6, 2024 at 12:20 p.m. ET in New York. A live webcast of the fireside chat wil...
-
2seventy bio, Inc . (Nasdaq: TSVT) will announce its second quarter 2024 financial results on Wednesday, August 7, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available on the Investors and Medi...
Important Investor News Alert (OTC: AABB)
-
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - October 9, 2024) - Investorideas.com , a global investor news source covering mining and metals stocks releases a snapshot looking at recent news and updates with gold stocks featuring Asia Broadband Inc. (OTC: AABB), a resource ...